skip to Main Content

Pancreatic Cancer Therapy May Be Improved by Targeting Neuroprotein Sortilin

Pancreatic Cancer Therapy May Be Improved by Targeting Neuroprotein Sortilin
Scientists say that an increased level of sortilin in pancreatic cancer cells that may open up the way to developing more effective treatment.

Sortilin is emerging as a key player in the regulation of neuronal viability and function, and there are increasing indications that it is involved in the deregulation of cancer cell viability. Sortilin is overexpressed in breast, lung, and thyroid cancer; it can promote cancer cell invasion in glioblastoma; and it participates in cancer cell adhesion and metastasis in colorectal cancer. However, its expression and impact in pancreatic cancer was not previously known. Read more . . .


Back To Top